Literature DB >> 8901477

Delayed cardioprotection is associated with the sub-cellular relocalisation of ventricular protein kinase C epsilon, but not p42/44MAPK.

S Wilson1, W Song, K Karoly, T Ravingerova, A Vegh, J Papp, S Tomisawa, J R Parratt, N J Pyne.   

Abstract

Both noradrenaline administration to rats and rapid cardiac pacing in dogs induces delayed protection of the heart against ischaemia-induced ventricular arrhythmias. In an attempt to establish molecular mechanisms underlying the delayed cardioprotection, we have examined the potential role of two kinases, PKC epsilon and p42/44MAPK. These protein kinases are expressed in the ventricles of the heart and are characterised by their ability to regulate ion-flux and gene transcription. In the rat p42MAPK is predominantly localised in the high-speed supernatant fraction of the ventricle homogenate, whereas p44MAPK is enriched in the nuclear low speed pellet. A small proportion of the p42MAPK is activated even in hearts from control animals. However, neither kinase is relocalised or activated by noradrenaline administration and this provides preliminary evidence the p42/44MAPK may not play a significant role in delayed protection in this species. In contrast, noradrenaline does induce the translocation of PKC epsilon to cell membranes, a response that is sustained for up to 4 h. However, PKC epsilon is down-regulated from the cytoplasm after 24 h post noradrenaline treatment. PKC epsilon is also translocated to the membrane in dogs that have been classically pre-conditioned and cardiac paced. In the latter case, translocation of PKC epsilon from the cytoplasm to the cell membrane is evident 24 h after pacing. These results indicate that the release of endogenous mediators may either inhibit down-regulation or elicit an increase in PKC epsilon mRNA expression. Therefore, in dog heart the subcellular relocalisation of PKC epsilon persists into the 'second window' and may play a central role in the molecular mechanism governing delayed cardioprotection. It is important in the future to identify either the gene products that are induced or the target protein(s) that are phosphorylated by PKC epsilon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901477     DOI: 10.1007/bf00240053

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

1.  Phorbol ester increases calcium current and simulates the effects of angiotensin II on cultured neonatal rat heart myocytes.

Authors:  A Döşemeci; R S Dhallan; N M Cohen; W J Lederer; T B Rogers
Journal:  Circ Res       Date:  1988-02       Impact factor: 17.367

Review 2.  A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?

Authors:  D M Yellon; G F Baxter
Journal:  J Mol Cell Cardiol       Date:  1995-04       Impact factor: 5.000

Review 3.  Protein kinase C isoform diversity in the heart.

Authors:  S F Steinberg; M Goldberg; V O Rybin
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

4.  Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium.

Authors:  G F Baxter; F M Goma; D M Yellon
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

5.  Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase.

Authors:  R C Venema; J F Kuo
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

6.  Activation of the c-Raf protein kinase by protein kinase C phosphorylation.

Authors:  O Sözeri; K Vollmer; M Liyanage; D Frith; G Kour; G E Mark; S Stabel
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

Review 7.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle.

Authors:  S Osada; K Mizuno; T C Saido; K Suzuki; T Kuroki; S Ohno
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

9.  Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing.

Authors:  A Vegh; J G Papp; J R Parratt
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

Review 10.  Domain interactions in protein kinase C.

Authors:  C J Pears; P J Parker
Journal:  J Cell Sci       Date:  1991-12       Impact factor: 5.285

View more
  7 in total

Review 1.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia.

Authors:  J C S Ho; S Wu; K W L Kam; J S K Sham; T M Wong
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  New insight into the signalling pathways of heat stress-induced myocardial preconditioning: protein kinase Cepsilon translocation and heat shock protein 27 phosphorylation.

Authors:  Claire Arnaud; Marie Joyeux-Faure; Serge Bottari; Diane Godin-Ribuot; Christophe Ribuot
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-03       Impact factor: 2.557

4.  Role of protein kinase C and 72 kDa heat shock protein in ischemic tolerance following heat stress in the rat heart.

Authors:  R C Kukreja; Y Z Qian; S Okubo; E E Flaherty
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

5.  Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury.

Authors:  A Adameová; M Kuzelová; E Andelová; V Faberová; D Pancza; P Svec; A Ziegelhöffer; T Ravingerová
Journal:  Mol Cell Biochem       Date:  2006-08-10       Impact factor: 3.396

Review 6.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

Review 7.  PRKCE gene encoding protein kinase C-epsilon-Dual roles at sarcomeres and mitochondria in cardiomyocytes.

Authors:  Sarah B Scruggs; Ding Wang; Peipei Ping
Journal:  Gene       Date:  2016-06-13       Impact factor: 3.688

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.